This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Sun Yat-Senuniversity. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations in Stem Cell Therapy: The Contributions of Peng Xiang
Introduction
Peng Xiang, a notable inventor based in Guangdong, China, has made significant strides in the field of regenerative medicine. With his innovative work focused on the differentiation of human induced pluripotent stem cells (hiPSCs), he is poised to impact treatments for hormonal imbalances such as hypogonadism.
Latest Patents
Peng Xiang holds a patent for a groundbreaking method titled "Method of committed differentiation of human induced pluripotent stem cells into Leydig cells and application of Leydig cells." This patent presents an in-vitro method that utilizes neural crest stem cells (NCSCs) to induce hiPSCs into Leydig cells. Remarkably, the Leydig cells derived from hiPSCs have been demonstrated through animal models to regenerate aging or damaged Leydig cells. This innovation provides a novel treatment avenue for patients suffering from testosterone deficiencies, particularly those with late-onset hypogonadism.
Career Highlights
Currently affiliated with Sun Yat-sen University, Peng Xiang's research efforts are focused on advancing stem cell therapy for various medical conditions. His expertise lies in applying stem cell technology to regenerative medicine, contributing to new therapeutic strategies that enhance patient quality of life.
Collaborations
Throughout his career, Peng has collaborated with esteemed colleagues such as Mei Hua Jiang and Weiqiang Li. These partnerships foster an environment of innovation and research, driving the exploration of regenerative medicine further into practical applications.
Conclusion
Peng Xiang's work exemplifies the potential of innovative research in stem cell therapy. His contributions not only highlight the importance of hiPSC differentiation but also pave the way for new treatments targeting hypogonadism. As he continues to collaborate and innovate, the medical community looks forward to the lasting impact his inventions will have in the field of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile